GetTopicDetailResponse(id=2fd31084835f, topicName=靶向葉酸受體α, introduction=靶向葉酸受體α, content=卵巢癌 靶向葉酸受體α, image=null, comments=0, allHits=702, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Mon Dec 11 11:27:01 CST 2023, time=2023-12-11, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=484284, tagList=[TagDto(tagId=484284, tagName=靶向葉酸受體α)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2174243, encodeId=31ce21e424324, content=<a href='/topic/show?id=08f236865a8' target=_blank style='color:#2F92EE;'>#卵巢癌#</a> <a href='/topic/show?id=2fd31084835f' target=_blank style='color:#2F92EE;'>#靶向葉酸受體α#</a>, objectTitle=卵巢癌化療耐藥？NEJM：創(chuàng)新療法帶來多方面生存獲益, objectType=article, longId=804459, objectId=111380445952, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668016376008_4754896.png, objectUrl=/article/show_article.do?id=111380445952, replyNumber=0, likeNumber=81, createdTime=2023-12-11, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=111380445952, moduleTitle=卵巢癌化療耐藥？NEJM：創(chuàng)新療法帶來多方面生存獲益, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=111380445952)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2023-12-11發(fā)表于上海
